Pelargonidin inhibits the PI3K/AKT/mTOR pathway and decreases MMP2, MMP9, N-cadherin, and VEGF protein expression and also inhibits the PI3K/AKT/mTOR pathway, preventing glioma vascularization and metastasis. Here, MTOR is linked to central nervous system cancer.